177 related articles for article (PubMed ID: 15885073)
1. Abstracts of the XV International Symposium on Drugs Affecting Lipid Metabolism, 24-27 October, 2004, Venice, Italy.
Int J Clin Pract Suppl; 2005 Jun; (148):3-16. PubMed ID: 15885073
[No Abstract] [Full Text] [Related]
2. [Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].
Ohfuji K; Yano S; Yamaguchi M; Smith G; Hirata M; Shimada H; Izuishi K; Shinagawa J; Matsunaga K
Nihon Yakurigaku Zasshi; 2005 Sep; 126(3):213-9. PubMed ID: 16272766
[No Abstract] [Full Text] [Related]
3. Abstracts from the XIV International Symposium on Drugs Affecting Lipid Metabolism. September 9-12, 2001, New York, USA.
Int J Clin Pract Suppl; 2002 Feb; (124):1-15. PubMed ID: 11939162
[No Abstract] [Full Text] [Related]
4. Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
Soto J; Fernandez de Bobadilla J
Value Health; 2006; 9(4):276-7; author reply 277-9. PubMed ID: 16903999
[No Abstract] [Full Text] [Related]
5. JUPITER strikes earth.
Fuster V; Bansilal S
Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):159. PubMed ID: 19234496
[No Abstract] [Full Text] [Related]
6. Treatment and prevention of dyslipidemia with rosuvastatin (Crestor).
Leonard KA
Nurse Pract; 2004 May; 29(5):11-5. PubMed ID: 15167530
[No Abstract] [Full Text] [Related]
7. Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.
Chello M; Spadaccio C
Cardiology; 2013; 124(1):36-7. PubMed ID: 23295545
[No Abstract] [Full Text] [Related]
8. Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?
Mori K; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S; Yoshida K
Clin Immunol; 2009 Mar; 130(3):375-7. PubMed ID: 19019736
[No Abstract] [Full Text] [Related]
9. Statin, the black box.
Hatem S; Boccara F
Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
[No Abstract] [Full Text] [Related]
10. Rosuvastatin treatment improves arterial stiffness with lowering blood pressure in healthy hypercholesterolemic patients.
Oh PC; Han SH; Koh KK; Lee K; Seo JG; Suh SY; Ahn T; Choi IS; Shin EK
Int J Cardiol; 2014 Oct; 176(3):1284-7. PubMed ID: 25135328
[No Abstract] [Full Text] [Related]
11. [Efficacy of lipid correcting therapy with the use of rosuvastatin].
Ivleva AIa
Kardiologiia; 2005; 45(6):71-80. PubMed ID: 16007037
[No Abstract] [Full Text] [Related]
12. CORONA, statins, and heart failure: who lost the crown?
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
[No Abstract] [Full Text] [Related]
13. Cosmic effect of rosuvastatin in COSMOS.
Adachi T; Ohsuzu F
Circ J; 2009 Nov; 73(11):2015-6. PubMed ID: 19851029
[No Abstract] [Full Text] [Related]
14. Cholesterol medication makes a debut in the U.S.
Heart Advis; 2003 Oct; 6(10):2. PubMed ID: 15106543
[No Abstract] [Full Text] [Related]
15. Is chronic severe anemia an independent predictor of poor outcomes?
Anand IS
Cardiology; 2011; 120(2):89-90. PubMed ID: 22142636
[No Abstract] [Full Text] [Related]
16. High-dose statins and atherosclerosis regression.
Rozenman Y
JAMA; 2006 Oct; 296(15):1836; author reply 1837. PubMed ID: 17047207
[No Abstract] [Full Text] [Related]
17. [How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].
Drapkina OM; Korneeva ON
Kardiologiia; 2012; 52(8):89-92. PubMed ID: 23098406
[No Abstract] [Full Text] [Related]
18. Is it time for HDL to change its tune?
Nicholls SJ; Puri R
Circulation; 2013 Sep; 128(11):1175-6. PubMed ID: 24002796
[No Abstract] [Full Text] [Related]
19. High-dose statins and atherosclerosis regression.
von Birgelen C; Hartmann M
JAMA; 2006 Oct; 296(15):1837; author reply 1837. PubMed ID: 17047210
[No Abstract] [Full Text] [Related]
20. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
Nicholls SJ; Uno K; Kataoka Y
Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
